TNBC By Krishna Prasad
Session 5: TNBC
Chairpersons :
S H Advani, S Hukku
Speaker :
Krishna Prasad
A Phase lb study of pembrolizumab (MK-3475) in patients (pts) with metastatic triple negative breast cancer (mTNBC)
Author: L. Buisseret
Conference: IMPAKT
Safety and efficacy of anti-Trop-2 antibody drug conjugate, sacituzumab govitecan (IMMU-132), in heavily pretreated patients with TNBC
Author:A. Bardia
Conference: SABCS
Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple negative breast cancer (TNBC). Abstract 2859. Presented at : 2015 American Association for Cancer Research (AACR) Meeting: April 18-22, 2015; Philadelphia, PA
Author: Emens LA
Conference: AACR 2015